Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study is designed to demonstrate superior or at least non-inferior efficacy of SBR759 in phoshate binding, versus sevelamer HCl and evaluate safety over a long term exposure. Efficacy will be measured by the number of patients with a serum phosphate level below or equal to 5.5 mg/dl (i.e. 1.78 mmol/L) at 12 weeks
Critère d'inclusion
- Hyperphosphataemia in patients with Chronic Kidney Disease (CKD) on hemodialysis